CD4 and COVID-19: The importance of vaccine-induced T cell responses is illustrated by studies not only monitoring the adaptive immunity to SARS-CoV-2 in patients, but also demonstrating that strong SARS-CoV-2–specific CD4+ or CD8+ T cell responses are associated with low disease severity in individuals with COVID-19 (5).